Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Derived Therapeutics is a pre-clinical stage biotechnology company focused on discovering and developing novel small molecule therapeutics for oncology. The company leverages a proprietary discovery platform designed to identify and optimize drug candidates against high-value, previously challenging biological targets. By integrating advanced computational methods with deep biological insights, Derived Therapeutics aims to create a pipeline of first-in-class or best-in-class treatments for various cancer types. The company is led by a team of experienced drug hunters and scientific experts dedicated to addressing significant unmet needs in the oncology space.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Derived.